Editor's Note Artificial intelligence (AI) is poised to overhaul drug development, with DeepMind CEO Demis Hassabis predicting that discovery timelines could shrink from more than a decade to just months. In a September 13 article from the Times of India, Hassabis described how AI models can identify drug candidates faster,…
The US Food and Drug Administration receives more than 100,000 medication-related reports, and some of them, according to the AORN Journal, “involve patient death.” AORN’s 2024 updated guidelines include safety updates for perioperative staff when handling, transporting, and administering medication, which can be a complex process prone to errors. In…
Editor's Note The Joint Commission announced, on August 22, that it had revised its requirements related to medication compounding for accredited hospitals and critical access hospitals, effective January 1, 2024. The revisions include Element of Performance (EP) 3 for National Patient Safety Goal (NPSG) NPSG.03.04.01: "Label all medications, medication containers,…
Editor's Note The Joint Commission, on July 19, announced that it has revised its Medication Compounding (MC) chapter for home care organizations and the Medication Compounding Certification (MDC) program, which is available to accredited hospitals, critical access hospitals, and home care pharmacy organizations. Among the revisions: Revising the requirements to…